Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study will seek to determine if whole genome sequencing (WGS) improves diagnostic rates, and outcomes for congenital diarrhea and enteropathy (CODE) patients. The investigator will enroll 180 patients in a randomized controlled study to either WGS or whole exome sequencing (WES). This study is designed to evaluate whether CODE patients would benefit from WGS guided precision medicine.
Epistemonikos ID: 43d248f9fe340bacb62fcd735b4047badb13d214
First added on: May 07, 2024